Palo Alto, CA, United States of America

Kara Andersen Reiter

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Kara Andersen Reiter

Introduction

Kara Andersen Reiter is a notable inventor based in Palo Alto, California. She has made significant contributions to the field of medical technology, particularly in the treatment of chronic obstructive pulmonary disease (COPD). With a total of two patents to her name, her work is paving the way for advancements in respiratory health.

Latest Patents

Kara's latest patents focus on a method for treating genetically associated chronic obstructive pulmonary disease. This innovative approach involves advancing at least one implant into the airway of a lung affected by the disease. The implant is designed to increase the tension of the lung, thereby improving its breathing function. This method represents a significant step forward in the treatment of COPD, offering new hope for patients suffering from this condition.

Career Highlights

Kara Andersen Reiter has established herself as a key figure in her field. Her work at Pneumrx, Inc. has allowed her to collaborate with other experts and contribute to groundbreaking research. Her dedication to improving patient outcomes through innovative solutions is evident in her patent filings and ongoing projects.

Collaborations

Kara works alongside Mark L Mathis, a colleague who shares her commitment to advancing medical technology. Their collaboration exemplifies the importance of teamwork in driving innovation and achieving successful outcomes in their research endeavors.

Conclusion

Kara Andersen Reiter's contributions to the field of medical technology, particularly in the treatment of chronic obstructive pulmonary disease, highlight her role as an influential inventor. Her innovative methods and dedication to improving respiratory health continue to inspire advancements in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…